STRUCTOS Trademark

Trademark Overview

On Wednesday, May 14, 2014, a trademark application was filed for STRUCTOS with the United States Patent and Trademark Office. The USPTO has given the STRUCTOS trademark a serial number of 86280637. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 14, 2016. This trademark is owned by NPS Pharmaceuticals, Inc.. The STRUCTOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, and bone metabolism disorders
structos

General Information

Serial Number86280637
Word MarkSTRUCTOS
Filing DateWednesday, May 14, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 14, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, and bone metabolism disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 27, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNPS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameNPS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Trademark Events

Event DateEvent Description
Monday, November 14, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 14, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 2, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 2, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 21, 2016EXTENSION 3 GRANTED
Wednesday, April 13, 2016EXTENSION 3 FILED
Wednesday, April 13, 2016TEAS EXTENSION RECEIVED
Thursday, October 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 21, 2015EXTENSION 2 GRANTED
Monday, October 12, 2015EXTENSION 2 FILED
Wednesday, October 21, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 12, 2015TEAS EXTENSION RECEIVED
Thursday, April 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 10, 2015EXTENSION 1 GRANTED
Friday, April 10, 2015EXTENSION 1 FILED
Friday, April 10, 2015TEAS EXTENSION RECEIVED
Friday, April 10, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 10, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 16, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 16, 2014ASSIGNED TO EXAMINER
Tuesday, May 27, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 17, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

structos disorders cells other neurological outside central nervous endocrine system metabolism